PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2006

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/09/2006
Quarter3
Financial Year End31/12/2006
The figureshave not been audited

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2006


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/09/2006 
30/09/2005 
30/09/2006 
30/09/2005 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
289,040
221,566
790,927
692,222
2Profit/(loss) before tax
10,675
8,854
27,852
41,415
3Profit/(loss) for the period
5,396
6,892
17,396
27,953
4Profit/(loss) attributable to ordinary equity holders of the parent
5,039
6,480
16,161
25,890
5Basic earnings/(loss) per share (sen)
4.71
6.23
15.11
25.19
6Proposed/Declared dividend per share (sen)
0.00
3.50
11.50
14.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR
END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)

3.0200
2.9900

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced13 Nov 2006  
CategoryFinancial Results
Reference NoPB-061113-68844